selegiline transdermal
General
Pronunciation:
se-le-ji-leen

Trade Name(s)
- Emsam
Ther. Class.
Pharm. Class.
monoamine oxidase type B inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Selegiline Transdermal." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109192/all/selegiline_transdermal.
Vallerand AHA, Sanoski CAC, Quiring CC. Selegiline transdermal. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109192/all/selegiline_transdermal. Accessed December 10, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Selegiline transdermal. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109192/all/selegiline_transdermal
Vallerand AHA, Sanoski CAC, Quiring CC. Selegiline Transdermal [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 10]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109192/all/selegiline_transdermal.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - selegiline transdermal
ID - 109192
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109192/all/selegiline_transdermal
PB - F.A. Davis Company
ET - 18
DB - The Washington Manual
DP - Unbound Medicine
ER -